PM ADDRESSES ONE WORLD TB SUMMIT IN VRARANASI
Prime Minister Shri Narendra D Modi addressed the One World TB Summit jointly organized by the Ministry of Health and Family Welfare (MoHFW) and the UN’s Stop TB Partnership in Varanasi on 24 March on the occasion of World Tuberculosis Day.
Razi
GP
Reena Rathi, SY Ahmed Khan, Ranjit Shirsath, Md. Shahnawaz Ali Quadri
Rita Sharma, JD
Hitesh Dingankar
Heema K
Medgate Today
It was in March 2018, during the End TB summit held in New Delhi, that PM Modiji had called on India to achieve TB-related SDG targets by 2025, five years ahead of the originally stipulated schedule. The One World TB Summit provided an opportunity to review progress made by India in achieving milestones as the country moves forward towards meeting its TB elimination objectives. It was also a forum for information exchange between participating medical health communities the world over, and learn from each others’ National TB Elimination Programmes. International delegates from more than 30 countries attended. In his address, Prime Minister Modi reaffirmed India’s commitment to ensuring a TB-free society and fulfilling its other resolution of global good through the One World TB Summit. He said: “Kashi will usher new energy towards global resolutions in the fight against a disease like TB. India’s efforts are a new model for the global war on TB” and stated “People’s participation in the fight against TB is India’s big contribution”.
He went on to add that “India is now working on the target of ending TB by the year 2025” and outlined the various initiatives launched by his Government such as the TB-Mukt Panchayat programme; the official pan-India rollout of a shorter TB Preventive Treatment (TPT); and the Family-centric care model for TB. He also released India’s Annual TB Report 2023.
The Prime Minister also awarded deserving States, UTs and districts that have made great strides in eradicating TB. He pointed out: “I would like that more and more countries get the benefit of all campaigns, innovations and modern technology of India”.
Have an insightful reading. Your suggestions are most welcome!
E-mail: editor@medgatetoday.com Website: www.medgatetoday.com
All right reserved by all everts are made to ensure that the information published is correct 'Medgate today’ holds no responsibility any unlikely errors that might occur.
Circulation Office: Advance Media Group Bldg.No-256/6 Office No-02, Near Pocket 10B, Jasola, (Behind Apollo Hospital) New Delhi - 110025 Tel: +91 - 11 - 2694 6348, 8448432883
Email: info@medgatetoday.com medgatetoday@gmail.com
Visit us: www.medgatetoday.com
Office No.18, 1St Floor, Crystal Plaza, Station Road, Mira Road(E), Mumbai-401107 Tel. 022-28102920
11, Krishnan, Koil Street 3rd Floor Rotary Lane Chennai - 600001 Dubai HealthCare City - Dubai
DIXIT PRINTERS, 124, Ground Floor Patparganj, Industrial Area, New Delhi-92
EDITOR SPEAK 4 Volume - XIV Issue - IV April 2023 Magazine 2023 January 2022 www.medgatetoday.com Editor-in-Chief Feature Editor Editorial Advisor Sales and Marketing Subscription & Circulation Creative Head Creative Designer Published by Mumbai Office Chennai Office Overseas Office UK UAE Singapore Printed by Md. Afzal Kamal
Ahsan
Capt. (Dr.) Sanjeev Sood
Sharad Lakhotia
Dr.
GOVERNMENT INTITIATIVES ERADICATING TB IN INDIA
DIAGNOSTIC INDUSTRY: OUTLOOK & FUTURE GROWTH
DR. MOOPEN’S FAMILY INCREASES 4% STAKE IN ASTER DM HEALTHCARE BUYING SHARES FOR RS 460 CRORE
MEDGATE TODAY LAUNCHED NEW EDITION HIGHLIGHTS FOR MIDDLE EAST & AFRICA
NEUBERG DIAGNOSTICS’ PATHFINDERS 2023 BRINGS TOGETHER 500+ DOCTORS AND EXPERTS TO UNDERSTAND THE ROLE OF CUTTING EDGE DIAGNOSTICS IN ENSURING
ARTIFICIAL INTELLIGENCE IN PATHOLOGY : EMERGING TOOLAN PERSPECTIVE
FOUNDER & DIRECTOR
DRG PATH LAB , NEW DELHI CHAIRMAN MEDICAL ADVISORY COMMITTEE, UNIPATH SPECAILTY LABORATORIES , AHMEDABAD
IVDS FOR ANALYSIS TO DETERMINE THE RESULTS OF A SPECIFIC TEST
CONSULTANT MICROBIOLOGIST
BGS GLENEAGLES GLOBAL HOSPITAL, BENGALURU
IMPORTANCE OF H3N2 DIAGNOSIS
MEDICAL LABORATORY DIRECTOR REDCLIFFE LABS
CANCER TREATMENT SERVICES INTERNATIONAL (CTSI), A WHOLLY OWNED SUBSIDIARY OF VARIAN MEDICAL SYSTEMS INC (A SIEMENS HEALTHINEERS COMPANY) APPOINTS HARISH TRIVEDI AS THE NEW CHIEF EXECUTIVE OFFICER, SOUTH ASIA
BREATHE EASY - INDIA TAKES ON TOBACCO AND TB
JAPAN-BASED TOYOTA TSUSHO CORPORATION AND TOKAI CORP PARTNER TO LAUNCH VALABHI HOSPITAL SERVICES
FUJIFILM INDIA LAUNCHES CAD EYE™ FUNCTION FOR UPPER GASTROINTESTINAL DIAGNOSIS AT THE GI UPDATE 2023 IN MYSURU
GENETICS AND GENOMICS: GAME CHANGER IN IDENTIFYING AND TREATING COMPLEX CARDIOVASCULAR DISEASES - DR. AMEET SATTUR
DIABETES IS THE MOST COMMON CAUSE OF RENAL FAILURE IN INDIA, AND UNCONTROLLED SUGAR LEVELS CAN DAMAGE THE KIDNEYDR. KARTHIK RAO
NEXAGE, INDIA’S FIRST TRENDY & STYLISH MEDICAL WEAR BRAND GETS OVERWHELMING RESPONSE FROM THE MEDICAL FRATERNITY VIVEK TIWARI
RADIOLOGY IS A DISCIPLINE OF MEDICINE THAT DIAGNOSES DR. RAJESH V HELAVAR
PRENATAL AND POSTNATAL CARE KITS (THE MANUAL OF LIFE)
RAHUL JAWADE
BRIDGING THE GAP: HOW HOSPITALSSTORE.COM IS REVOLUTIONIZING THE MEDICAL EQUIPMENT MARKET IN INDIA SONU KUMAR YADAV
“YATRA NARYASTU PUJYANTE RAMANTE TATRA DEVATA” DR. VISHAL SAXENA
EMERGING SOLUTIONS OFFER HOPE FOR TACKLING DRUG-RESISTANT TUBERCULOSIS CHALLENGES DR. SATISH KS
POINT OF CARE DIVISION OF AGAPPE – ACUTE CARE THOMAS JOHN
MEDGATE TODAY SUCCESSFULLY LAUNCHED NEW EDITION FOR
MIDDLE EAST & AFRICA
15TH MARCH 2023
4TH INTERNATIONAL MEETING ON WEIGHT-BEARING MRI
26TH MARCH 2023, NEW DELHI, INDIA
MEDICALL INDIA'S LARGEST NO.1 HOSPITAL EQUIPMENT EXPO17,18,19 MARCH, HYDERABAD
VOLUME - XIV ISSUE - IV APRIL 2023 NEWS UPDATE EXPERT VIEW DR. RAVI GAUR DR. SOHINI SENGUPTA JATIN MAHAJAN DR. RASHMI M 08 10 12 14 16 18 20 32 34 36 38 40 42 44 46 48 50 51 52
INSIDE
DOCTOR SPEAK
PRODUCT LINE POST EVENT
IMPROVED OUTCOMES MANAGING DIRECTOR J MITRA & CO PVT. LTD.
COVER 31 30 26 24 22
1800 425 7151 / 1800 891 7251 / 1800 270 7151 Toll Free Scan Here for more info PREMIUM SOLUTIONS AT ITS FINEST “Agappe Hills”, Pattimattom (PO), Dist. Ernakulam, Kerala - 683 562, India. TEL: + 91 484 2867000 | productcorp@agappe.in | www.agappe.com Fully Automated Biochemistry Analyzer 6 Part Automatic Hematology Analyzer AUTOMATIC CHEMILUMINESCENCE IMMUNOASSAY SYSTEM 800/1200 Test/Hr 180 Test/Hr 100 Test/Hr
810
F
DR. MOOPEN’S FAMILY INCREASES 4% STAKE IN ASTER DM HEALTHCARE BUYING SHARES FOR RS 460 CRORE (DH 207 MILLION)
• The increase of 4% stake from 37.88% reaffirms the family’s commitment to the business in India and GCC
• Listed in India, the valuation of Aster DM Healthcare stands at USD $ 1.4 billion as on date
The promoters of Aster DM Healthcare have increased their shareholding in the India listed company by 4% from 37.88% to 41.88%, after acquiring additional stake from one of the large private equity investors at an additional investment of Rs 460 Crore (Dh. 207 million).
Speaking on the increase in stake, Dr. Azad Moopen, Founder Chairman and Managing Director of Aster DM Healthcare said, “The increase of our stake in Aster DM Healthcare is a reiteration of our confidence in the business across geographies and our commitment to the patients and employees who have placed their trust in us. As a family we are fully committed to Aster and promise our continued involvement in GCC and India businesses both in terms of ownership and management.
Aster DM Healthcare, with a turnover of Rs. 10,253 crore or AED 5 billion in FY 2021-22, is performing very well during this FY in turnover and profits with an exciting stage of growth, due to restructuring of India and GCC businesses being pursued actively. In India we are moving ahead with new projects like 350-bedded Aster Capital Hospital in Trivandrum - Kerala, 200 bedded Aster MIMS Hospital in
Kasargod - Kerala, 150-bedded Aster Narayanadri Hospital in Tirupati –Andhra Pradesh, 100-bedded Aster G Madegowda Hospital in Mandya –Karnataka among others. We have also rolled out 239 Aster pharmacies and 177 Aster Labs & patient experience centres already. With 4,095 beds in 15 hospitals in India going up to 4,670 in 18 hospitals next financial year, Aster shall be connecting all the above through the myAster App that is going to be launched this year to give omni channel care to our customers.
The launch of 181 bed Aster Royal Hospital in Oman, 101 bed Aster Hospital in Sharjah and the acquisition of a 126 bedded hospital in Al Qusais which would be operational soon, will make Aster one of the largest healthcare providers in GCC with 15 hospitals, 113 clinics and 257 pharmacies. The company has embarked on a plan to roll out 250 new Aster Pharmacies in the Kingdom of Saudi Arabia. The Omni channel healthcare delivery is being tied up with the myAster App which has already received 352,000+ downloads within a short period since its launch.
Aster DM Healthcare, with its presence in 7 countries and 828 establishments employs 29,108 people and serves over 18 million patients a year.”
UPDATE NEWS 8 April 2023 www.medgatetoday.com
Dr. Azad Moopen Chairman & Managing Director Aster DM Healthcare
